vs

Side-by-side financial comparison of B&G Foods, Inc. (BGS) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.

B&G Foods, Inc. is the larger business by last-quarter revenue ($439.3M vs $397.6M, roughly 1.1× Guardian Pharmacy Services, Inc.). Guardian Pharmacy Services, Inc. runs the higher net margin — 5.3% vs -4.4%, a 9.6% gap on every dollar of revenue.

B&G Foods, Inc. is an American branded foods holding company based in Parsippany, New Jersey. The company was formed in 1996 to acquire Bloch & Guggenheimer, a Manhattan-based producer of pickles, relish and condiments which had been founded in 1889.

CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.

BGS vs GRDN — Head-to-Head

Bigger by revenue
BGS
BGS
1.1× larger
BGS
$439.3M
$397.6M
GRDN
Higher net margin
GRDN
GRDN
9.6% more per $
GRDN
5.3%
-4.4%
BGS

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BGS
BGS
GRDN
GRDN
Revenue
$439.3M
$397.6M
Net Profit
$-19.1M
$20.9M
Gross Margin
22.5%
21.5%
Operating Margin
2.5%
7.7%
Net Margin
-4.4%
5.3%
Revenue YoY
-4.7%
Net Profit YoY
-356.5%
EPS (diluted)
$-0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BGS
BGS
GRDN
GRDN
Q4 25
$397.6M
Q3 25
$439.3M
$377.4M
Q2 25
$424.4M
$344.3M
Q1 25
$425.4M
$329.3M
Q4 24
$551.6M
Q3 24
$461.1M
$314.4M
Q2 24
$444.6M
Q1 24
$475.2M
Net Profit
BGS
BGS
GRDN
GRDN
Q4 25
$20.9M
Q3 25
$-19.1M
$9.8M
Q2 25
$-9.8M
$9.0M
Q1 25
$835.0K
$9.4M
Q4 24
$-222.4M
Q3 24
$7.5M
$-122.0M
Q2 24
$3.9M
Q1 24
$-40.2M
Gross Margin
BGS
BGS
GRDN
GRDN
Q4 25
21.5%
Q3 25
22.5%
19.8%
Q2 25
20.5%
19.8%
Q1 25
21.2%
19.5%
Q4 24
21.5%
Q3 24
22.2%
19.4%
Q2 24
20.7%
Q1 24
22.9%
Operating Margin
BGS
BGS
GRDN
GRDN
Q4 25
7.7%
Q3 25
2.5%
4.3%
Q2 25
5.2%
3.7%
Q1 25
8.4%
3.9%
Q4 24
-46.6%
Q3 24
11.1%
-33.3%
Q2 24
9.9%
Q1 24
-3.3%
Net Margin
BGS
BGS
GRDN
GRDN
Q4 25
5.3%
Q3 25
-4.4%
2.6%
Q2 25
-2.3%
2.6%
Q1 25
0.2%
2.9%
Q4 24
-40.3%
Q3 24
1.6%
-38.8%
Q2 24
0.9%
Q1 24
-8.5%
EPS (diluted)
BGS
BGS
GRDN
GRDN
Q4 25
Q3 25
$-0.24
Q2 25
$-0.12
Q1 25
$0.01
Q4 24
$-2.81
Q3 24
$0.09
Q2 24
$0.05
Q1 24
$-0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BGS
BGS
GRDN
GRDN
Cash + ST InvestmentsLiquidity on hand
$60.9M
$65.6M
Total DebtLower is stronger
$2.0B
$0
Stockholders' EquityBook value
$470.7M
$217.9M
Total Assets
$2.9B
$412.7M
Debt / EquityLower = less leverage
4.30×
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BGS
BGS
GRDN
GRDN
Q4 25
$65.6M
Q3 25
$60.9M
$36.5M
Q2 25
$54.1M
$18.8M
Q1 25
$61.2M
$14.0M
Q4 24
$50.6M
Q3 24
$54.7M
$37.2M
Q2 24
$40.3M
Q1 24
$42.5M
Total Debt
BGS
BGS
GRDN
GRDN
Q4 25
$0
Q3 25
$2.0B
Q2 25
$2.0B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$2.1B
$34.3M
Q2 24
$2.0B
Q1 24
$2.0B
Stockholders' Equity
BGS
BGS
GRDN
GRDN
Q4 25
$217.9M
Q3 25
$470.7M
$195.5M
Q2 25
$501.4M
$179.7M
Q1 25
$513.1M
$163.2M
Q4 24
$524.8M
Q3 24
$755.3M
$133.9M
Q2 24
$765.0M
Q1 24
$781.2M
Total Assets
BGS
BGS
GRDN
GRDN
Q4 25
$412.7M
Q3 25
$2.9B
$390.0M
Q2 25
$2.9B
$356.3M
Q1 25
$3.0B
$334.0M
Q4 24
$3.0B
Q3 24
$3.4B
$348.0M
Q2 24
$3.4B
Q1 24
$3.4B
Debt / Equity
BGS
BGS
GRDN
GRDN
Q4 25
0.00×
Q3 25
4.30×
Q2 25
3.97×
Q1 25
3.91×
Q4 24
3.85×
Q3 24
2.75×
0.26×
Q2 24
2.67×
Q1 24
2.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BGS
BGS
GRDN
GRDN
Operating Cash FlowLast quarter
$-64.6M
$34.6M
Free Cash FlowOCF − Capex
$-70.7M
FCF MarginFCF / Revenue
-16.1%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
1.65×
TTM Free Cash FlowTrailing 4 quarters
$54.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BGS
BGS
GRDN
GRDN
Q4 25
$34.6M
Q3 25
$-64.6M
$28.2M
Q2 25
$17.8M
$19.9M
Q1 25
$52.7M
$17.6M
Q4 24
$80.3M
Q3 24
$4.2M
Q2 24
$11.3M
Q1 24
$35.1M
Free Cash Flow
BGS
BGS
GRDN
GRDN
Q4 25
Q3 25
$-70.7M
$24.2M
Q2 25
$11.5M
Q1 25
$42.4M
Q4 24
$71.7M
Q3 24
$-679.0K
Q2 24
$5.2M
Q1 24
$27.5M
FCF Margin
BGS
BGS
GRDN
GRDN
Q4 25
Q3 25
-16.1%
6.4%
Q2 25
2.7%
Q1 25
10.0%
Q4 24
13.0%
Q3 24
-0.1%
Q2 24
1.2%
Q1 24
5.8%
Capex Intensity
BGS
BGS
GRDN
GRDN
Q4 25
Q3 25
1.4%
1.1%
Q2 25
1.5%
Q1 25
2.4%
Q4 24
1.6%
Q3 24
1.0%
Q2 24
1.4%
Q1 24
1.6%
Cash Conversion
BGS
BGS
GRDN
GRDN
Q4 25
1.65×
Q3 25
2.87×
Q2 25
2.21×
Q1 25
63.17×
1.86×
Q4 24
Q3 24
0.56×
Q2 24
2.87×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BGS
BGS

Specialty Segment$150.5M34%
Meals Segment$110.0M25%
Spices And Flavor Solutions Segment$101.4M23%
Frozen And Vegetables Segment$77.4M18%

GRDN
GRDN

Segment breakdown not available.

Related Comparisons